Seelos Therapeutics Inc.

09/13/2022 | Press release | Distributed by Public on 09/13/2022 06:23

Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and[...]